GlaxoSmithKline Says Albrecht Doesn’t Allow Paxil Suicide Verdict To Be Reinstated

(July 11, 2019, 12:01 PM EDT) -- CHICAGO — GlaxoSmithKline (GSK) in a July 8 brief tells an Illinois federal court that the U.S. Supreme Court’s recent ruling on the “clear evidence” standard for drug warning label cases is not a change in law that warrants overturning the reversal of a $3 million Paxil suicide verdict (Wendy B. Dolin, et al. v. SmithKlineBeecham Corporation, et al., No. 12-6403, N.D. Ill.)....

Attached Documents

Related Sections